BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10899677)

  • 1. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters.
    Sonis ST; Peterson RL; Edwards LJ; Lucey CA; Wang L; Mason L; Login G; Ymamkawa M; Moses G; Bouchard P; Hayes LL; Bedrosian C; Dorner AJ
    Oral Oncol; 2000 Jul; 36(4):373-81. PubMed ID: 10899677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biological basis for the attenuation of mucositis: the example of interleukin-11.
    Sonis S; Edwards L; Lucey C
    Leukemia; 1999 Jun; 13(6):831-4. PubMed ID: 10360368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel model of megavoltage radiation-induced oral mucositis in hamsters: Role of inflammatory cytokines and nitric oxide.
    Moura JF; Mota JM; Leite CA; Wong DV; Bezerra NP; Brito GA; Lima V; Cunha FQ; Ribeiro RA
    Int J Radiat Biol; 2015 Jun; 91(6):500-9. PubMed ID: 25758466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters.
    Sonis ST; Van Vugt AG; McDonald J; Dotoli E; Schwertschlag U; Szklut P; Keith J
    Cytokine; 1997 Aug; 9(8):605-12. PubMed ID: 9245489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of radiation- and chemoradiation-induced mucositis using gamma-D-glutamyl-L-tryptophan (SCV-07).
    Watkins B; Pouliot K; Fey E; Tuthill C; Sonis S
    Oral Dis; 2010 Oct; 16(7):655-60. PubMed ID: 20412446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11.
    Sonis S; Muska A; O'Brien J; Van Vugt A; Langer-Safer P; Keith J
    Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):261-6. PubMed ID: 7492924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethyl Sulfoxide Prevents Radiation-Induced Oral Mucositis Through Facilitating DNA Double-Strand Break Repair in Epithelial Stem Cells.
    Yang C; Tang H; Wang L; Peng R; Bai F; Shan Y; Yu Z; Zhou P; Cong Y
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1577-1589. PubMed ID: 30092334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of basic fibroblast growth factor on radiation-induced oral mucositis in male Syrian hamsters.
    Sumikawa S; Watanabe S; Tanaka M; Tanaka A; Araki H
    Int J Radiat Biol; 2017 Dec; 93(12):1343-1349. PubMed ID: 29034752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation treatment breaks and ulcerative mucositis in head and neck cancer.
    Russo G; Haddad R; Posner M; Machtay M
    Oncologist; 2008 Aug; 13(8):886-98. PubMed ID: 18701763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters.
    Lima V; Brito GA; Cunha FQ; Rebouças CG; Falcão BA; Augusto RF; Souza ML; Leitão BT; Ribeiro RA
    Eur J Oral Sci; 2005 Jun; 113(3):210-7. PubMed ID: 15953245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of topical external medicine for 5-fluorouracil-induced oral mucositis in hamsters.
    Mitsuhashi H; Suemaru K; Li B; Cui R; Araki H
    Eur J Pharmacol; 2006 Dec; 551(1-3):152-5. PubMed ID: 17046745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy.
    Epstein JB; Gorsky M; Guglietta A; Le N; Sonis ST
    Cancer; 2000 Dec; 89(11):2258-65. PubMed ID: 11147596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer therapy-related oral mucositis.
    Redding SW
    J Dent Educ; 2005 Aug; 69(8):919-29. PubMed ID: 16081575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
    Chung YL; Lee MY; Pui NN
    Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the hamster cheek pouch as a model for radiation-induced oral mucositis, and evaluation of the protective effects of keratinocyte growth factor using this model.
    Watanabe S; Suemaru K; Nakanishi M; Nakajima N; Tanaka M; Tanaka A; Araki H
    Int J Radiat Biol; 2014 Oct; 90(10):884-91. PubMed ID: 24827853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of caspases protects mice from radiation-induced oral mucositis and abolishes the cleavage of RNA-binding protein HuR.
    Talwar S; House R; Sundaramurthy S; Balasubramanian S; Yu H; Palanisamy V
    J Biol Chem; 2014 Feb; 289(6):3487-500. PubMed ID: 24362034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucositis: biology and management.
    Treister N; Sonis S
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):123-9. PubMed ID: 17413415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
    Bossi P; Bergamini C; Miceli R; Cova A; Orlandi E; Resteghini C; Locati L; Alfieri S; Imbimbo M; Granata R; Mariani L; Iacovelli NA; Huber V; Cavallo A; Licitra L; Rivoltini L
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):959-966. PubMed ID: 27745982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
    El-Sayed S; Nabid A; Shelley W; Hay J; Balogh J; Gelinas M; MacKenzie R; Read N; Berthelet E; Lau H; Epstein J; Delvecchio P; Ganguly PK; Wong F; Burns P; Tu D; Pater J
    J Clin Oncol; 2002 Oct; 20(19):3956-63. PubMed ID: 12351592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.